Sandoz Group AG | WebDisclosure

Basculer en Français

10726	Companies
229878	Keywords
158330	Articles
122053	Press releases

Home
Companies
Sandoz Group AG

PRESS RELEASE

published on 01/14/2026 at 12:00, 6 months 1 day ago

Sandoz confirms European Commission approval of Ondibta® (insulin glargine), strengthening overall biosimilars leadership and position in diabetes
Sandoz confirms European Commission approval of Ondibta® (insulin glargine), strengthening overall biosimilars leadership and position in diabetes. Expected launch by early 2027

Diabetes European Commission Biosimilars Sandoz Ondibta
BRIEF

published on 01/12/2026 at 15:05, 6 months 2 days ago

Sandoz dévoile sa stratégie pour une « décennie d'or » des médicaments abordables

Stratégie De Marché Biosimilaires Groupe Sandoz AG Médicaments Abordables Décennie Dorée
BRIEF

published on 01/12/2026 at 15:05, 6 months 2 days ago

Sandoz Unveils Strategy for 'Golden Decade' of Affordable Medicines

Market Strategy Biosimilars Sandoz Group AG Golden Decade Affordable Medicines
PRESS RELEASE

published on 01/12/2026 at 15:00, 6 months 2 days ago

Sandoz CEO, speaking at 44th Annual J.P. Morgan Healthcare Conference, will outline plans to capitalize on unprecedented ’golden decade’ of affordable medicines opportunity
Sandoz CEO to outline plans for capturing the unprecedented 'golden decade' of affordable medicines opportunity at the 44th Annual J.P. Morgan Healthcare Conference

CEO Sandoz J.P. Morgan Healthcare Conference Golden Decade Affordable Medicines
BRIEF

published on 12/08/2025 at 07:05, 7 months 7 days ago

Sandoz acquiert Just-Evotec Biologics EU SAS pour renforcer son leadership dans le domaine des biosimilaires

Acquisition Soins De Santé Biosimilaires Groupe Sandoz AG Fabrication Continue
BRIEF

published on 12/08/2025 at 07:05, 7 months 7 days ago

Sandoz Acquires Just-Evotec Biologics EU SAS to Boost Biosimilar Leadership

Acquisition Healthcare Biosimilars Sandoz Group AG Continuous Manufacturing
PRESS RELEASE

published on 12/08/2025 at 07:00, 7 months 7 days ago

Sandoz completes strategic acquisition of Just-Evotec Biologics EU SAS, asserting biosimilars leadership
Sandoz completes strategic acquisition of Just-Evotec Biologics EU SAS, asserting biosimilars leadership. Expands capabilities for biosimilars with cutting-edge technology

Acquisition Biosimilars Sandoz Just-Evotec Biologics EU SAS Continuous-manufacturing Technology
BRIEF

published on 12/01/2025 at 07:05, 7 months 14 days ago

Sandoz Launches Denosumab Biosimilars in Europe

Bone Health Sandoz Denosumab Biosimilars Wyost® Jubbonti®
BRIEF

published on 12/01/2025 at 07:05, 7 months 14 days ago

Sandoz lance des biosimilaires de dénosumab en Europe

Sandoz Wyost® Jubbonti® Biosimilaires Du Dénosumab Santé Osseuse
PRESS RELEASE

published on 12/01/2025 at 07:00, 7 months 14 days ago

Sandoz launches denosumab biosimilars in Europe, providing affordable treatment option for cancer-related bone disease and osteoporosis for millions of patients
Sandoz launches denosumab biosimilars in Europe, providing affordable treatment options for cancer-related bone disease and osteoporosis. The European launch marks a key milestone in Sandoz's growth strategy

Europe Biosimilars Cancer Osteoporosis Sandoz

Accesswire

Published on 07/15/2026 at 14:00, 39 minutes ago

GameSquare Provides Update to Capital Allocation Strategy
Published on 07/15/2026 at 14:00, 39 minutes ago

Dateline Returns Widespread REE Mineralisation at Music Valley
Published on 07/15/2026 at 13:30, 1 hour 9 minutes ago

Nextech3D.ai Launches KraftyLab Intelligence(TM), an AI-Powered Workforce Intelligence and Employee Engagement Platform
Published on 07/15/2026 at 13:30, 1 hour 9 minutes ago

Reeflex Reports Third Quarter Fiscal 2026 Results and Return to Quarterly Profitability
Published on 07/15/2026 at 13:00, 1 hour 39 minutes ago

Nepra Foods Advances Planned Acquisition of Idaho Beverage Manufacturing Operations Following Port of Lewiston Approval

View all ACCESSWIRE

EQS Group

Published on 07/15/2026 at 14:26, 13 minutes ago

BIRKENSTOCK ANNOUNCES FISCAL THIRD QUARTER (ENDED JUNE 30, 2026) RESULTS DATE AND CONFERENCE CALL SCHEDULED FOR AUGUST 13, 2026
Published on 07/15/2026 at 13:30, 1 hour 9 minutes ago

Leading the Network 2030: WBBA Officially Launches AI-Net, a Globally Authoritative Data Communications Certification
Published on 07/15/2026 at 13:30, 1 hour 9 minutes ago

The technology breakthroughs behind Huawei's next-generation Smart String Grid-Forming ESS Platform
Published on 07/15/2026 at 13:15, 1 hour 24 minutes ago

Now is Your Moment: Huawei Unlocks New Possibilities for Every Moment Through All-Scenario Innovation
Published on 07/15/2026 at 13:05, 1 hour 34 minutes ago

Septa Pharmaceuticals Inc. Acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada

Les Echos

Published on 07/15/2026 at 08:41, 5 hours 57 minutes ago

ENGIE - Déclaration du nombre total d'actions et de droits de vote au 30 juin 2026
Published on 07/15/2026 at 08:00, 6 hours 39 minutes ago

Groupe PLC, accompagné par son actionnaire majoritaire IDI, complète son offre par l’acquisition de Floralpina
Published on 07/13/2026 at 18:00, 1 day 20 hours ago

CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense
Published on 07/13/2026 at 18:00, 1 day 20 hours ago

PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Published on 07/13/2026 at 18:00, 1 day 20 hours ago

THERMADOR GROUPE : 2026 half-year turnover

View all LES ECHOS COMFI WIRE